Evidence map›Paper›PMID 29735715›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

ZNRF3 functions in mammalian sex determination by inhibiting canonical WNT signaling.

Abigail Harris, Pam Siggers, Silvia Corrochano, Nick Warr, Danielle Sagar, Daniel T Grimes, Makoto Suzuki, Rebecca D Burdine, Feng Cong, Bon-Kyoung Koo and 12 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 117 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. How relevant is the mouse model for understanding human sex determination?International journal of biological sciences · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Two Novel Heterozygous Variants in RecA2 Domain of DHX37 Cause 46,XY Gonadal Dysgenesis and Testicular Regression Syndrome.Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation · 2023
    Article
  18. Article
  19. Factors within the Developing Embryo and Ovarian Microenvironment That Influence Primordial Germ Cell Fate.Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation · 2023
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 8 institutions in 6 countries.

Abigail HarrisMammalian Genetics Unit, Medical Research Council, Harwell Institute, OX11 0RD Oxfordshire, United Kingdom.
Pam SiggersMammalian Genetics Unit, Medical Research Council, Harwell Institute, OX11 0RD Oxfordshire, United Kingdom.
Silvia CorrochanoMammalian Genetics Unit, Medical Research Council, Harwell Institute, OX11 0RD Oxfordshire, United Kingdom.ORCID 0000-0003-0958-0083
Nick WarrMammalian Genetics Unit, Medical Research Council, Harwell Institute, OX11 0RD Oxfordshire, United Kingdom.
Danielle SagarMammalian Genetics Unit, Medical Research Council, Harwell Institute, OX11 0RD Oxfordshire, United Kingdom.
Daniel T GrimesDepartment of Molecular Biology, Princeton University, Princeton, NJ 08544.
Makoto SuzukiDepartment of Molecular Biology, Princeton University, Princeton, NJ 08544.ORCID 0000-0002-5494-6593
Rebecca D BurdineDepartment of Molecular Biology, Princeton University, Princeton, NJ 08544.ORCID 0000-0001-6620-5015
Feng CongNovartis Institutes for Biomedical Research, Cambridge, MA 02139.
Bon-Kyoung KooHubrecht Institute, University Medical Center, 3584 CT Utrecht, The Netherlands.
Hans CleversHubrecht Institute, University Medical Center, 3584 CT Utrecht, The Netherlands.
Isabelle StévantDepartment of Genetic Medicine and Development, University of Geneva Medical School, CH 1211 Geneva 4, Switzerland.
Serge NefDepartment of Genetic Medicine and Development, University of Geneva Medical School, CH 1211 Geneva 4, Switzerland.
Sara WellsThe Mary Lyon Centre, Medical Research Council Harwell Institute, OX11 0RD Oxfordshire, United Kingdom.
Raja BraunerUniversité Paris Descartes and Paediatric Endocrinology Unit, Fondation Opthalmologique Adolphe de Rothschild, 75019 Paris, France.
Bochra Ben RhoumaHuman Molecular Genetics Laboratory, Faculty of Medicine, University of Sfax, 3030 Sfax, Tunisia.
Neïla BelguithHuman Molecular Genetics Laboratory, Faculty of Medicine, University of Sfax, 3030 Sfax, Tunisia.
Caroline EozenouHuman Developmental Genetics, Institut Pasteur, 75724 Paris, France.
Joelle Bignon-TopalovicHuman Developmental Genetics, Institut Pasteur, 75724 Paris, France.
Anu BashambooHuman Developmental Genetics, Institut Pasteur, 75724 Paris, France.
Ken McElreaveyHuman Developmental Genetics, Institut Pasteur, 75724 Paris, France kenneth.mcelreavey@pasteur.fr a.greenfield@har.mrc.ac.uk.
Andy GreenfieldMammalian Genetics Unit, Medical Research Council, Harwell Institute, OX11 0RD Oxfordshire, United Kingdom; kenneth.mcelreavey@pasteur.fr a.greenfield@har.mrc.ac.uk.ORCID 0000-0002-1477-1776
Mary Lyon Centre at MRC Harwell · GBInstitut Pasteur · FRPrinceton University · USUniversity Medical Center · USUniversity of Geneva · CHUniversity of Sfax · TNMedical Research Council · GBUniversité Paris Cité · FR

Funding

Connecting Polycystin Signaling to Asymmetric Nodal ExpressionR01HD048584 · NICHD · PRINCETON UNIVERSITY · PI BURDINE, REBECCA D. · 2007 to 2016
$3.5M
The Role of Cilia and Cerebrospinal Fluid Flow in Spine Development and Human DiseaseK99AR070905 · NIAMS · PRINCETON UNIVERSITY · PI GRIMES, DANIEL T · 2017 to 2018
$122k
Medical Research Council MC_U142684167Medical Research Council MC_UP_1502/1NIAMS NIH HHS K99 AR070905NICHD NIH HHS R01 HD048584
6 · The paper itself

Abstract

Mammalian sex determination is controlled by the antagonistic interactions of two genetic pathways: The SRY-SOX9-FGF9 network promotes testis determination partly by opposing proovarian pathways, while RSPO1/WNT-β-catenin/FOXL2 signals control ovary development by inhibiting SRY-SOX9-FGF9. The molecular basis of this mutual antagonism is unclear. Here we show that ZNRF3, a WNT signaling antagonist and direct target of RSPO1-mediated inhibition, is required for sex determination in mice. XY mice lacking ZNRF3 exhibit complete or partial gonadal sex reversal, or related defects. These abnormalities are associated with ectopic WNT/β-catenin activity and reduced

Indexed as

Sex DifferentiationAdolescentAdultAnimalsbeta CateninCells, CulturedDisorders of Sex DevelopmentEmbryo, NonmammalianFemaleGene Expression Regulation, DevelopmentalGonadsHumansMaleMiceMutation, MissenseR-Spondinsbeta CateninCTNNB1 protein, humanRSPO1 protein, humanR-SpondinsSOX9 Transcription FactorThrombospondinsUbiquitin-Protein LigasesWnt ProteinsZNRF3 protein, humanZnrf3 protein, mouseDSDorganogenesissex determinationWNT signalingZNRF3

Identifiers

PMID29735715
PMCPMC6003506
OpenAlexW2800286806

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.